CMI/Compas Offers Critical POV and Direction on FDA-Issued Social Media Advertising Guidance

FDA this week issued highly anticipated guidance on social media advertising in an extensive, multi-page document. A CMI/Compas POV, just made available for download on their website, summarizes the key highlights of the guidance, with clear impact and direction to pharma marketers and publishers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

King of Prussia, PA (PRWEB) January 17, 2014

FDA this week issued highly anticipated guidance on social media advertising in an extensive, multi-page document. A CMI/Compas POV, just made available for download on their website, summarizes the key highlights of the guidance, with clear impact and direction to pharma marketers and publishers.

“FDA Loosens Reigns on Social Advertising,” authored by industry expert Justin Freid, enables pharma marketers and publishers to quickly get up to speed on the critical points of the FDA’s news, with actionable insights to assist in their to assist in their navigation of the complex world surrounding social media marketing.

For a copy of the free POV, visit http://www.cmimedia.com/insights/cmi-whitepapers.

About CMI/Compas
Well-known as a media planning and buying organization for healthcare clients, sister agencies Communications Media, Inc. (CMI) and Compas, Inc. together form the indispensable strategic marketing partner to the world’s game-changers in health, offering guidance at every level of marketing. CMI/Compas focuses on core service offerings of Media, Innovation, Customer Insights, Technology, and Buying. CMI/Compas is laser-focused on helping clients move the promotional needle. CMI/Compas has offices in Philadelphia; King of Prussia, PA; Pennsauken, NJ; and New York. The family of companies is actively recruiting for healthcare marketing jobs via http://www.cmirecruiter.com.


Contact